Who owns Neuphoria Therapeutics Inc.?
- Ticker: NEUP
- CUSIP Number: 64136e102
Tip: Access positions for across all investors
Analyze quarterly positions in Neuphoria Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neuphoria Therapeutics stock
Who bought or sold Neuphoria Therapeutics Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AdvisorShares Investments | 59k | $691k | -14% | Sep 2025 |
|
| Prosperity Wealth Management | 30k | $352k | 0% | Sep 2025 |
|
| Diadema Partners | 22k | $253k | 100% | Sep 2025 |
|
| Vanguard Group | 21k | $247k | 100% | Sep 2025 |
|
| Millennium Management | 18k | $216k | 100% | Sep 2025 |
|
| Jane Street | 16k | $185k | 100% | Sep 2025 |
|
| Geode Capital Management | 13k | $153k | 100% | Sep 2025 |
|
| Merck & Co | 10k | $118k | 0% | Sep 2025 |
|
| UBS Group | 2.2k | $26k | 100% | Sep 2025 |
|
| Tower Research Capital | 410.00 | $4.8k | 100% | Sep 2025 |
|
| Rhumbline Advisers | 33.00 | $389.000700 | 0% | Sep 2025 |
|
| Morgan Stanley | 7.00 | $50.000300 | 100% | Jun 2025 |
|
| FMR | 2.00 | $24.000000 | 100% | Sep 2025 |
|
Who sold out of Neuphoria Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Lynx1 Capital Management | Jun 2025 | 46k | $325k |
| Citadel Advisors | Jun 2025 | 15k | $104k |
| Cyndeo Wealth Partners | Jun 2025 | 10k | $71k |